Protagenic Therapeutics Inc. (@protagenic) header
Protagenic Therapeutics Inc. (@protagenic) profile picture

Protagenic Therapeutics Inc.

@protagenic

We have created a portfolio of novel neuropeptides that are being evaluated for the treatment of stress-related disorders.

 New York, New York
protagenic.com
Joined October 2020
  • Tweets7
  • Following8
  • Followers41
3Media
Photo by Protagenic Therapeutics Inc. (@protagenic)Photo by Protagenic Therapeutics Inc. (@protagenic)Photo by Protagenic Therapeutics Inc. (@protagenic)
Register Now: Protagenic Therapeutics, Inc. (#PTIX) to Host Virtual Science Review Wednesday, Sep 8th at 10 AM ET The focus will be a scientific review of its programs designed for the treatment of patients with Depression, PTSD, Anxiety and Addiction protagenic.com/webinars/
Image from Protagenic Therapeutics Inc. (@protagenic)
6
1
Protagenic Therapeutics, Inc. (#PTIX) Virtual Science Review: A review of our programs designed for the treatment of patients with Depression, PTSD, Anxiety & Addiction Watch the full webinar here: protagenic.com/publications-…
1
Protagenic's CMO, Bob Stein, MD, PhD is participating in the Advances in Mental Health Virtual Conference, presented by @maximgrp, hosted by @mvestllc, on Sept. 22nd, 9am – 2 pm ET. This conference will be live on M-Vest. To attend, sign up to become an M-Vest member
1
Pioneering Neuronal Health: Aiming to be an innovative, safe, and effective treatment platform that regulates stress response and restores healthy brain function. Introducing the brand new Protagenic Website: protagenic.com/
Protagenic Therapeutics: Not a classical antidepressant. Not a psychedelic. A new frontier.

Protagenic Therapeutics: Not a classical antidepressant. Not a psychedelic. A new frontier.

Not a classical antidepressant. Not a psychedelic. A new frontier. Protagenic Therapeutics is developing PT00114 (a first-in-class synthetic analog of TCAP) to treat anxiety, depression, PTSD and...

protagenic.com
2
1
1
1
A recent investor forum with Q&A featuring Dr. Maurizio Fava, principal investigator of the planned PT00114 Phase I/IIa clinical trial, is now available for viewing here: protagenic.com/webinar-on-de…
Image from Protagenic Therapeutics Inc. (@protagenic)
Register now: Protagenic Therapeutics, Inc. (PTIX) is hosting a key opinion leader (KOL) webinar focused on PT00114 for the regulation of stress in patients with Depression, PTSD, Anxiety and Addiction on Tuesday, July 13 at 10:00AM ET. Register here: protagenic.com/webinar-on-de…
Image from Protagenic Therapeutics Inc. (@protagenic)
Load more